An evaluation of the efficacy and safety of colistimethate sodium injection in patients with multidrug-resistant Gram-negative bacterial infection - A multicenter, unblinded clinical study
Not Applicable
- Conditions
- multidrug-resistant Gram-negative bacterial infection
- Registration Number
- JPRN-UMIN000008226
- Lead Sponsor
- The clinical study group for MDR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Allergy for polymyxin. Woman who is pregnant or has chance to be pregnant or breast-feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response at the end of administration.
- Secondary Outcome Measures
Name Time Method